source
- Schrödinger launches Tectora Therapeutics with $55 million Series A to target immunology and inflammationSchrödinger announced the formation of Tectora Therapeutics, a new biotech focused on immune‑mediated diseases, backed by a $55 million Series A financing round. As part of the launch, Schrödinger…
- Sandoz announces $300 million biosimilar factory in Slovenia and plans to expand pipeline sevenfoldSandoz, the generic and biosimilar division of Novartis, said it will invest $300 million to build a new biosimilar manufacturing facility in Slovenia. The company also announced that its newly cr…